Other products from "AESKU.DIAGNOSTICS GMBH & CO. KG"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 04250289503631 3514 AESKULISA DGP-G is a solid phase enzyme immunoassay employing synthetic, deamida AESKULISA DGP-G is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative and qualitative detection of IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® DGP-G
2 04250289504591 30-7514US 30-7514US AESKULISA DGP-G is a solid phase enzyme immunoassay employing synthetic, deamida AESKULISA DGP-G is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative and qualitative detection of IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). 30'+30'+30' automation incubation. MST Antibodies, Gliadin 2 AESKULISA® DGP-G
3 04250289504461 51.100.US 51.100.US AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear and / or cytoplasmic autoantibodies in human serum. The assay is a tool in the differential diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren’s syndrome (SS), polymyositis and dermatomyositis. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKUSLIDES® ANA-HEp-2
4 04250289503105 7501US 7501US AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgA antibodies against gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® Glia-A
5 04250289501484 3501 AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgA antibodies against gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® Glia-A
6 04250289503082 7206US 7206US AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2gly AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI highly purified from human plasma for the separate quantitative and qualitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum. Anti-β2glycoprotein I antibodies recognize specific epitopes on human β2-glycoprotein I which are expressed only when β2-glycoprotein I interacts with lipid membranes or when absorbed to other surfaces (e.g. microtiter plate). The assay is an aid in the diagnosis and risk of primary and secondary antiphospholipid syndrome (APS). MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-GM
7 04250289502856 30-7501US 30-7501US AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-A is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgA antibodies against gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). 30'+30'+30' automation incubation. MST Antibodies, Gliadin 2 AESKULISA® Glia-A
8 04250289502832 30-7206US 30-7206US AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2gly AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI highly purified from human plasma for the separate quantitative and qualitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum. Anti-β2glycoprotein I antibodies recognize specific epitopes on human β2-glycoprotein I which are expressed only when β2-glycoprotein I interacts with lipid membranes or when absorbed to other surfaces (e.g. microtiter plate). The assay is an aid in the diagnosis and risk of primary and secondary antiphospholipid syndrome (APS).30'+30'+30' automation incubation. MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-GM
9 04250289500869 3206 AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2gly AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI highly purified from human plasma for the separate quantitative and qualitative detection of IgG and / or IgM antibodies against β2-glycoprotein I in human serum. Anti-β2glycoprotein I antibodies recognize specific epitopes on human β2-glycoprotein I which are expressed only when β2-glycoprotein I interacts with lipid membranes or when absorbed to other surfaces (e.g. microtiter plate). The assay is an aid in the diagnosis and risk of primary and secondary antiphospholipid syndrome (APS). MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-GM
10 04250289500005 51.100 AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear and / or cytoplasmic autoantibodies in human serum. The assay is a tool in the differential diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren’s syndrome (SS), polymyositis and dermatomyositis. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKUSLIDES® ANA-HEp-2
11 04250289510394 53.100.US AESKUSLIDES® nDNA (Crithidia luciliae) is an indirect immunofluorescence assay u AESKUSLIDES® nDNA (Crithidia luciliae) is an indirect immunofluorescence assay utilizing Crithidia luciliae coated slides as a substrate for the qualitative and/or semi-quantitative determination of antibodies to native double stranded DNA (dsDNA) in human serum. LSW Anti-Dna Antibody, Antigen And Control 2 AESKUSLIDES nDNA (Crithidia luciliae)
12 04250289503501 30-7115US 30-7115US AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualita AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis. 30'+30'+30' automation incubation. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKULISA® ANA-HEp-2
13 04250289500845 3204 AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay employing highly pu AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative and qualitative detection of IgG and /or IgM antibodies against cardiolipin in human serum. Anti-cardiolipin antibodies mainly recognize specific epitopes on a complex composed of cardiolipin and ß2glycoprotein I which are only expressed when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-GM
14 04250289503075 7205US 7205US AESKULISA b2 Glyco-A is a solid phase enzyme immunoassay employing native b2 gly AESKULISA b2 Glyco-A is a solid phase enzyme immunoassay employing native b2 glycoprotein I highly purified from human plasma for the semiquantitative and qualitative detection of IgA antibodies against ß2 glycoprotein I in human serum. The presence of anti-b2 glycoprotein I antibodies in conjuction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary andsecondary antiphospholipid syndrome. MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-A
15 04250289503068 7204US 7204US AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay employing highly pu AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative and qualitative detection of IgG and /or IgM antibodies against cardiolipin in human serum. Anti-cardiolipin antibodies mainly recognize specific epitopes on a complex composed of cardiolipin and ß2glycoprotein I which are only expressed when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-GM
16 04250289503020 7115US 7115US AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualita AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKULISA® ANA-HEp-2
17 04250289502955 7105US 7105US AESKULISA snRNP-C is a solid phase enzyme immunoassay for the quantitative and q AESKULISA snRNP-C is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against the snRNP complex in human serum. The assay employs native human U1-snRNP complex highly purified from the cell-line HeLa. The U1-snRNP complex comprises the Smith antigen (Sm) and RNPs, the 70kDa U1specific protein plus protein A and C. The assay is a tool for the diagnosis of mixed connective tissue diseases (MCTD) and systemic lupus erythematosus (SLE) LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® snRNP-C
18 04250289500579 3115 AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualita AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKULISA® ANA-HEp-2
19 04250289502825 30-7205US 30-7205US AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 gly AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 glycoprotein I highly purified from human plasma for the quantitative and qualitative detection of IgA antibodies against β2 glycoprotein I in human serum. Anti-β2 glycoprotein I antibodies recognize specific epitopes on human β2 glycoprotein I which are expressed only when β2 glycoprotein I interacts with lipid membranes or when absorbed to other surfaces (e.g. microtiter plate). The assay is an aid in the diagnosis and risk of primary and secondary antiphospholipid syndrome. 30'+30'+30' automation incubation. MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-A
20 04250289500852 3205 AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 gly AESKULISA β2 Glyco-A is a solid phase enzyme immunoassay employing native β2 glycoprotein I highly purified from human plasma for the quantitative and qualitative detection of IgA antibodies against β2 glycoprotein I in human serum. Anti-β2 glycoprotein I antibodies recognize specific epitopes on human β2 glycoprotein I which are expressed only when β2 glycoprotein I interacts with lipid membranes or when absorbed to other surfaces (e.g. microtiter plate). The assay is an aid in the diagnosis and risk of primary and secondary antiphospholipid syndrome. MSV System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) 2 AESKULISA® ß2-Glyco-A
21 04250289500470 3105 AESKULISA snRNP-C is a solid phase enzyme immunoassay for the quantitative and q AESKULISA snRNP-C is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against the snRNP complex in human serum. The assay employs native human U1-snRNP complex highly purified from the cell-line HeLa. The U1-snRNP complex comprises the Smith antigen (Sm) and RNPs, the 70kDa U1specific protein plus protein A and C. The assay is a tool for the diagnosis of mixed connective tissue diseases (MCTD) and systemic lupus erythematosus (SLE) LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® snRNP-C
22 04250289503143 7507US 7507US AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly pu AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the quantitative and qualitative detection of IgA anti-Saccharomyces cerevisiae antibodies (ASCA) in human serum. ASCA recognize specifically mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease. NBT Antibodies,Saccharomyces Cerevisiae (S.Cerevisiae) 2 AESKULISA® ASCA-A
23 04250289500548 3112 AESKULISA Cenp-B is a solid phase enzyme immunoassay employing purified recombin AESKULISA Cenp-B is a solid phase enzyme immunoassay employing purified recombinant human 80 kDa centromere protein B (Cenp-B) for the quantitative and qualitative detection of IgG antibodies against Cenp-B in human serum. The assay ensures the highest specificity and sensitivity for the detection of antibodies against centromere protein B, which serves as an aid in the diagnosis of systemic sclerosis and CREST syndrome. LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® Cenp-B
24 04250289503006 7112US 7112US AESKULISA Cenp-B is a solid phase enzyme immunoassay employing purified recombin AESKULISA Cenp-B is a solid phase enzyme immunoassay employing purified recombinant human 80 kDa centromere protein B (Cenp-B) for the quantitative and qualitative detection of IgG antibodies against Cenp-B in human serum. The assay ensures the highest specificity and sensitivity for the detection of antibodies against centromere protein B, which serves as an aid in the diagnosis of systemic sclerosis and CREST syndrome. LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® Cenp-B
25 04250289502979 7107US 7107US AESKULISA SS-A is a solid phase enzyme immunoassay for the quantitative and qual AESKULISA SS-A is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against Ro/ SS-A in human serum. The assay employs human Ro/SS-A antigen composed of highly purified native 60kDa and recombinant human 52 kDa Ro/SS-A protein. Anti-SS-A antibodies are species-specific (directed against human protein only) and preferentially react with the native 60kDa molecule where as most antibodies to the 52 kDa protein prefer the denatured molecule. The assay is a tool in the diagnosis of Sjögren`s syndrome (SS) and systemic lupus erythematosus (SLE). LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® SS-A
26 04250289502894 30-7507US 30-7507US AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly pu AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the quantitative and qualitative detection of IgA anti-Saccharomyces cerevisiae antibodies (ASCA) in human serum. ASCA recognize specifically mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease. 30'+30'+30' automation incubation. NBT Antibodies,Saccharomyces Cerevisiae (S.Cerevisiae) 2 AESKULISA® ASCA-A
27 04250289501521 3507 AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly pu AESKULISA ASCA-A is a solid phase enzyme immunoassay (ELISA) employing highly purified mannan for the quantitative and qualitative detection of IgA anti-Saccharomyces cerevisiae antibodies (ASCA) in human serum. ASCA recognize specifically mannan, a component of the outer cell wall of yeast. The assay is highly specific and sensitive for Crohn`s disease. NBT Antibodies,Saccharomyces Cerevisiae (S.Cerevisiae) 2 AESKULISA® ASCA-A
28 04250289500494 3107 AESKULISA SS-A is a solid phase enzyme immunoassay for the quantitative and qual AESKULISA SS-A is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against Ro/ SS-A in human serum. The assay employs human Ro/SS-A antigen composed of highly purified native 60kDa and recombinant human 52 kDa Ro/SS-A protein. Anti-SS-A antibodies are species-specific (directed against human protein only) and preferentially react with the native 60kDa molecule where as most antibodies to the 52 kDa protein prefer the denatured molecule. The assay is a tool in the diagnosis of Sjögren`s syndrome (SS) and systemic lupus erythematosus (SLE). LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® SS-A
29 04250289510387 54.051.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca) 2 AESKUSLIDES ANCA Formalin
30 04250289510363 54.101.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca) 2 AESKUSLIDES ANCA Formalin
31 04250289504843 30-7515US 30-7515US AESKULISA DGP-Check is an in-vitro diagnostic device. This solid phase enzyme im AESKULISA DGP-Check is an in-vitro diagnostic device. This solid phase enzyme immunoassay employs synthetic, deamidated gliadin-derived peptides for the combined semiquantitative and qualitative detection of IgA and IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum.30'+30'+30' automation incubation. MST Antibodies, Gliadin 2 AESKULISA® DGP-Check
32 04250289503112 7502US 7502US AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgG antibodies against Gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® Glia-G
33 04250289503044 7202US 7202US AESKULISA Cardiolipin-Check is a solid phase enzyme immunoassay employing highly AESKULISA Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative and qualitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum. Anticardiolipin antibodies mainly recognize specific epitopes on a complex composed out of cardiolipin and ß2-glycoprotein I which are expressed only when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-Check
34 04250289500821 3202 AESKULISA Cardiolipin-Check is a solid phase enzyme immunoassay employing highly AESKULISA Cardiolipin-Check is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the combined quantitative and qualitative detection of IgA, IgG and IgM antibodies against cardiolipin in human serum. Anticardiolipin antibodies mainly recognize specific epitopes on a complex composed out of cardiolipin and ß2-glycoprotein I which are expressed only when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-Check
35 04250289502948 7104US 7104US AESKULISA U1-70 is a solid phase enzyme immunoassay employing recombinant human AESKULISA U1-70 is a solid phase enzyme immunoassay employing recombinant human 70 kDa protein of the U1-snRNP complex for the quantitative and qualitative detection of antibodies against the 70 kDa U1-RNP in human serum. The assay is a tool in the diagnosis of mixed connective tissue diseases (MCTD) and systemic lupus erythematosus (SLE). LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® U1-70
36 04250289502863 30-7502US 30-7502US AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgG antibodies against Gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). 30'-30'-30' incubation time MST Antibodies, Gliadin 2 AESKULISA® Glia-G
37 04250289501491 3502 AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified a AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgG antibodies against Gliadin in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® Glia-G
38 04250289500463 3104 AESKULISA U1-70 is a solid phase enzyme immunoassay employing recombinant human AESKULISA U1-70 is a solid phase enzyme immunoassay employing recombinant human 70 kDa protein of the U1-snRNP complex for the quantitative and qualitative detection of antibodies against the 70 kDa U1-RNP in human serum. The assay is a tool in the diagnosis of mixed connective tissue diseases (MCTD) and systemic lupus erythematosus (SLE). LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® U1-70
39 04250289504584 30-7513US 30-7513US AESKULISA DGP-A is a solid phase enzyme immunoassay employing synthetic, deamida AESKULISA DGP-A is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative and qualitative detection of IgA antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). 30'+30'+30' automation incubation. MST Antibodies, Gliadin 2 AESKULISA® DGP-A
40 04250289503624 3513 AESKULISA DGP-A is a solid phase enzyme immunoassay employing synthetic, deamida AESKULISA DGP-A is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the quantitative and qualitative detection of IgA antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® DGP-A
41 04250289503129 7503US 7503US The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the q The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum. MVM Autoantibodies, Endomysial(Tissue Transglutaminase) 2 AESKULISA tTg-A New Generation
42 04250289503051 7203US 7203US AESKULISA Cardiolipin-A is a solid phase enzyme immunoassay employing highly pur AESKULISA Cardiolipin-A is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative and qualitative detection of IgA antibodies against cardiolipin in human serum. Anti-cardiolipin antibodies mainly recognize specific epitopes on a complex composed out of cardiolipin and ß2-glycoprotein I which are expressed only when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-A
43 04250289500838 3203 AESKULISA Cardiolipin-A is a solid phase enzyme immunoassay employing highly pur AESKULISA Cardiolipin-A is a solid phase enzyme immunoassay employing highly purified cardiolipin plus native human ß2-glycoprotein I for the quantitative and qualitative detection of IgA antibodies against cardiolipin in human serum. Anti-cardiolipin antibodies mainly recognize specific epitopes on a complex composed out of cardiolipin and ß2-glycoprotein I which are expressed only when ß2-glycoprotein I interacts with cardiolipin. The assay is an aid in the diagnosis and risk estimation of thrombosis in patients with systemic lupus erythematosus (SLE). MID System, Test, Anticardiolipin Immunological 2 AESKULISA® Cardiolipin-A
44 04250289502931 7103US 7103US AESKULISA ENA-6Pro is a solid phase enzyme immunoassay for the separate semiquan AESKULISA ENA-6Pro is a solid phase enzyme immunoassay for the separate semiquantitative detection of IgG antibodies against six cellular and nuclear antigens in human serum. The wells are coated with recombinant SS-B, SS-A 52 kDa, Scl 70, Jo-1 and highly purified native human snRNP/Sm, Sm and SS-A 60 kDa. The assay is a tool in the differential diagnosis of systemic rheumatic diseases. LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® ENA-6Pro
45 04250289502870 30-7503US 30-7503US The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the q The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum. 30'+30'+30' automation incubation. MVM Autoantibodies, Endomysial(Tissue Transglutaminase) 2 AESKULISA tTg-A New Generation
46 04250289500456 3103 AESKULISA ENA-6Pro is a solid phase enzyme immunoassay for the separate semiquan AESKULISA ENA-6Pro is a solid phase enzyme immunoassay for the separate semiquantitative detection of IgG antibodies against six cellular and nuclear antigens in human serum. The wells are coated with recombinant SS-B, SS-A 52 kDa, Scl 70, Jo-1 and highly purified native human snRNP/Sm, Sm and SS-A 60 kDa. The assay is a tool in the differential diagnosis of systemic rheumatic diseases. LJM Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls 2 AESKULISA® ENA-6Pro
47 04250289510370 54.050.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca) 2 AESKUSLIDES ANCA Ethanol
48 04250289510356 54.100.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca) 2 AESKUSLIDES ANCA Ethanol
49 04250289504935 51.101.US 51.101.US AESKUSLIDES® ANA HEp-2-Gamma is an indirect fluorescent antibody assay utilizing AESKUSLIDES® ANA HEp-2-Gamma is an indirect fluorescent antibody assay utilizing HEp-2 cell coated slides as a substrate for the qualitative and/or semi-quantitative determination of antinuclear antibodies (ANA) in human serum. DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control 2 AESKUSLIDES® ANA-HEp-2 gamma
50 04250289503679 3515 AESKULISA DGP-Check is a solid phase enzyme immunoassay employing synthetic, dea AESKULISA DGP-Check is a solid phase enzyme immunoassay employing synthetic, deamidated gliadin-derived peptides for the combined quantitative and qualitative detection of IgA and IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum. The assay is a tool in the diagnosis of celiac disease (gluten-sensitive enteropathy). MST Antibodies, Gliadin 2 AESKULISA® DGP-Check
Other products with the same Product Code "MOB"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 08426950767053 704338 1. 1 x 7mL Mounting Medium2. 1 x 15mL FITC IgG Conjugate with DAPI3. 1 x Coversl 1. 1 x 7mL Mounting Medium2. 1 x 15mL FITC IgG Conjugate with DAPI3. 1 x Coverslips (20 ea)4. 1 x 0.5mL IFA System Negative Control5. 1 x 0.5mL cANCA Positive6. 1 x 0.5mL pANCA Positive7. 20 x ANCA (Ethanol Fixed Human Neutrophil) Slide (12 well)8. 2 x 25mL PBS II Concentrate (40x) NOVA Lite® DAPI ANCA (Ethanol) Kit INOVA DIAGNOSTICS, INC.
2 08426950767046 704337 1. 1 x 7mL Mounting Medium2. 1 x 15mL FITC IgG Conjugate with DAPI3. 1 x Coversl 1. 1 x 7mL Mounting Medium2. 1 x 15mL FITC IgG Conjugate with DAPI3. 1 x Coverslips (20 ea)4. 1 x 0.5mL IFA System Negative Control5. 1 x 0.5mL cANCA Positive6. 1 x 0.5mL pANCA Positive7. 20 x ANCA (Formalin Fixed Human Neutrophil) Slide (12 well)8. 2 x 25mL PBS II Concentrate (40x) NOVA Lite® DAPI ANCA (Formalin) Kit INOVA DIAGNOSTICS, INC.
3 08426950602125 708301 1. 20x ANCA (Ethanol Fixed Human Neutrophil), slides - 12 wells2. 1x 15mL FITC I 1. 20x ANCA (Ethanol Fixed Human Neutrophil), slides - 12 wells2. 1x 15mL FITC IgG Conjugate with DAPI 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 2x 25mL PBS II Concentrate (40x)7. 1x 7mL Mounting Medium8. 1x 20 Coverslips9. 1x Direction Insert NOVA Lite® ANCA (Ethanol) Kit with DAPI INOVA DIAGNOSTICS, INC.
4 08426950602118 708300 "1 .20x ANCA (Formalin Fixed Human Neutrophil), slides - 12 wells2. 1x 15mL FITC "1 .20x ANCA (Formalin Fixed Human Neutrophil), slides - 12 wells2. 1x 15mL FITC IgG Conjugate with DAPI 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 2x25mL PBS II Concentrate (40x)8. 1x 7mL Mounting Medium9. 1x 20 Coverslips10. 1x Direction Insert" NOVA Lite® ANCA (Formalin) Kit with DAPI INOVA DIAGNOSTICS, INC.
5 08426950594550 704660.10 1 .Instruction leaflet: Giving full assay details.2.QC Certificate: Indicating t 1 .Instruction leaflet: Giving full assay details.2.QC Certificate: Indicating the expected performance of the batch.3. PR3 SC Coated Wells: 10 plates containing 12 breakapart 8 well strips coated with PR3 antigen, colour coded red. Each plate is packaged in a re-sealable foil bag containing 2 desiccant pouches.4.Type III Sample Diluent: 19 bottles containing 50mL of buffer for sample dilution. Coloured yellow, ready to use.5. HRP Wash Concentrate: 10 bottles containing 25mL of a 40-fold concentrated buffer for washing the wells. 6. PR3 SC ELISA Calibrators: 25 bottles (5 bottles each) containing 1.2mL of diluted human serum, with the following concentrations of anti-PR3 autoantibody: 100, 33.3, 11.1, 3.7, 1.23 U/mL. Ready to use.7. PR3 SC Positive Control: 5 bottles containing 1.2mL of diluted human serum. Ready to use.8.ELISA Negative Control: 5 bottles containing 1.2mL of diluted human serum. Ready to use.9. HRP PR3 SC IgG Conjugate: 10 bottles containing 10mL of purified peroxidase labelled antibody to human IgG. Coloured blue, ready to use.10.TMB Chromogen: 10 bottles containing 10mL TMB substrate. Ready to use.11. HRP Stop Solution: 10 bottles containing 10mL of 0.344M Sulfuric acid. Ready to use. QUANTA Lite® PR3 SC ELISA Bulk Pack INOVA DIAGNOSTICS, INC.
6 08426950594512 704655.10 1. Instruction leaflet: Giving full assay details.2. QC Certificate: Indicating 1. Instruction leaflet: Giving full assay details.2. QC Certificate: Indicating the expected performance of the batch.3. MPO SC Coated Wells: 10 plates containing 12 breakapart 8 well strips coated with MPO antigen, colour coded green. Each plate is packaged in a re-sealable foil bag containing 2 desiccant pouches.4. Type III Sample Diluent: 19 bottles containing 50mL of buffer for sample dilution. Coloured yellow, ready to use.5. HRP Wash Concentrate: 10 bottles containing 25mL of a 40-fold concentrated buffer for washing the wells. 6. MPO SC ELISA Calibrators: 25 bottles (5 bottles each) containing 1.2mL of diluted human serum, with the following concentrations of anti-MPO autoantibody: 100, 33.3, 11.1, 3.7, 1.23 U/mL. Ready to use.7.MPO SC Positive Control: 5 bottles containing 1.2mL of diluted human serum. The expected value is given on the QC certificate.Ready to use.8. ELISA Negative Control: 5 bottles containing 1.2mL of diluted human serum. The expected value is given on the QC certificate. Ready to use.9. HRP MPO SC IgG Conjugate: 10 bottles containing 10mL of purified peroxidase labelled antibody to human IgG. Coloured blue, ready to use.10. TMB Chromogen: 10 bottles containing 10mL TMB substrate. Ready to use.11.HRP Stop Solution: 10 bottles containing 10mL of 0.344M Sulfuric acid. Ready to use. QUANTA Lite® MPO SC ELISA Bulk Pack INOVA DIAGNOSTICS, INC.
7 08426950594109 708297 1. 20x12-well ANCA Neutrophil substrate slides (formalin-fixed)2. 1x 1mL pANCA P 1. 20x12-well ANCA Neutrophil substrate slides (formalin-fixed)2. 1x 1mL pANCA Positive Control (prediluted) 3. 1x 1mL cANCA Positive Control (prediluted) 4. 1x 1mL ANA Positive Control (prediluted) 5. 1x 1mL IFA System Negative Control6. 1x 15mL anti Human IgG AFF Fluorescein with Evans Blue7. 2x 25mL PBS II Concentrate (40x)8. 1x 3mL 1% Evans Blue 9. 1x 10mL Mounting Medium10. 1x 20 Coverslips11. 1x Instruction leaflet NOVA Lite® ANCA Formalin Kit INOVA DIAGNOSTICS, INC.
8 08426950594055 708299 1. 10x 6-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 4mL FITC 1. 10x 6-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 4mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 1x 25mL PBS II Concentrate (40x)7. 1x 7mL Mounting Medium8. 1x 10 Coverslips NOVA Lite® ANCA Kit INOVA DIAGNOSTICS, INC.
9 08426950554103 708295 1. 10x 6-well ANCA Neutrophil substrate slides (formalin-fixed)2. 1x 1mL pANCA P 1. 10x 6-well ANCA Neutrophil substrate slides (formalin-fixed)2. 1x 1mL pANCA Positive Control (prediluted) 3. 1x 1mL ANA Positive Control (prediluted) 4. 1x 1mL IFA System Negative Control5. 1x7mL anti Human IgG AFF Fluorescein with Evans Blue6. 2x 25mL PBS II Concentrate (40x) 7. 1x 3mL 1% Evans Blue Counterstain8. 1x 3mL Mounting Medium9. 1x 10 Coverslips10. 1x Instruction leaflet NOVA Lite® ANCA Formalin Kit INOVA DIAGNOSTICS, INC.
10 08426950544258 701138 1. 1 QUANTA Flash PR3 Reagent Cartridge QUANTA Flash® PR3 Reagents INOVA DIAGNOSTICS, INC.
11 08426950544241 704660 "1. Instruction leaflet: 2. QC Certificate3. PR3 SC Coated Wells: 12 breakapar "1. Instruction leaflet: 2. QC Certificate3. PR3 SC Coated Wells: 12 breakapart 8 well strips 4. Type III Sample Diluent: 2 bottles containing 50mL 5. HRP Wash Concentrate: 1 bottle containing 25mL6. PR3 SC ELISA Calibrators: 5 bottles each containing 1.2mL 7. PR3 SC Positive Control: 1 bottle containing 1.2mL 8. ELISA Negative Control: 1 bottle containing 1.2mL 9. HRP PR3 SC IgG Conjugate: 1 bottle containing 10mL 10. TMB Chromogen: 1 bottle containing 10mL 11. HRP Stop Solution: 1 bottle containing 10mL QUANTA Lite® PR3 SC ELISA INOVA DIAGNOSTICS, INC.
12 08426950544197 701133 1. 1 QUANTA Flash MPO Reagent Cartridge QUANTA Flash® MPO Reagents INOVA DIAGNOSTICS, INC.
13 08426950544180 704655 1. Instruction leaflet: Giving full assay details.2. QC Certificate: Indicating 1. Instruction leaflet: Giving full assay details.2. QC Certificate: Indicating the expected performance of the batch.3. MPO SC Coated Wells: 12 breakapart 8 well strips coated with MPO antigen, colour coded green. Each plate is packaged in a re-sealable foil bag containing 2 desiccant pouches.4. Type III Sample Diluent: 2 bottles containing 50mL of buffer for sample dilution. Coloured yellow, ready to use.5. HRP Wash Concentrate: 1 bottle containing 25mL of a 40-fold concentrated buffer for washing the wells. 6. MPO SC ELISA Calibrators: 5 bottles each containing 1.2mL of diluted human serum, with the following concentrations of anti-MPO autoantibody: 100, 33.3, 11.1, 3.7, 1.23 U/mL. Ready to use.7. MPO SC Positive Control: 1 bottle containing 1.2mL of diluted human serum. The expected value is given on the QC certificate.Ready to use.8. ELISA Negative Control: 1 bottle containing 1.2mL of diluted human serum. The expected value is given on the QC certificate. Ready to use.9. HRP MPO SC IgG Conjugate: 1 bottle containing 10mL of purified peroxidase labelled antibody to human IgG. Coloured blue, ready to use.10.TMB Chromogen: 1 bottle containing 10mL TMB substrate. Ready to use.11. HRP Stop Solution: 1 bottle containing 10mL of 0.344M Sulfuric acid. Ready to use. QUANTA Lite® MPO SC ELISA INOVA DIAGNOSTICS, INC.
14 08426950513995 708296 1. 20x 12-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 15mL FI 1. 20x 12-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 15mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 2x 25mL PBS II Concentrate (40x)7. 1x 7mL Mounting Medium8. 1x 20 Coverslips NOVA Lite® ANCA Kit INOVA DIAGNOSTICS, INC.
15 08426950512912 708298 1. 20x 12-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 15mL FI 1. 20x 12-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 15mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 2x 25mL PBS II Concentrate (40x)7. 1x 7mL Mounting Medium8. 1x 20 Coverslips NOVA Lite® ANCA Kit INOVA DIAGNOSTICS, INC.
16 08426950456216 708290 1. 10x 6-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 4mL FITC 1. 10x 6-well ANCA ethanol-fixed human neutrophil substrate slides2. 1x 4mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL cANCA Positive4. 1x 0.5 mL pANCA Positive 5. 1x 0.5mL IFA System Negative Control6. 1x 25mL PBS II Concentrate (40x)7. 1x 7mL Mounting Medium8. 1x 10 Coverslips NOVA Lite® ANCA Kit INOVA DIAGNOSTICS, INC.
17 08426950448303 708705 1. 1x PR-3 IgG ELISA microwell plate (12-1 x 8 wells), with holder2. 1x 1.2mL pr 1. 1x PR-3 IgG ELISA microwell plate (12-1 x 8 wells), with holder2. 1x 1.2mL prediluted ELISA Negative Control 3. 1x 1.2mL prediluted PR-3 IgG ELISA Low Positive4. 1x 1.2mL prediluted PR-3 IgG ELISA High Positive5. 1x 50mL HRP Sample Diluent6. 1x 25mL HRP Wash Concentrate, 40x concentrate7. 1x 10mL HRP IgG Conjugate, (goat), anti-human IgG8. 1x 10mL TMB Chromogen9. 1x 10mL HRP Stop Solution, 0.344M Sulfuric Acid QUANTA Lite® PR-3 IgG ELISA INOVA DIAGNOSTICS, INC.
18 08426950448280 708700 1. 1x MPO IgG ELISA microwell plate (12-1 x 8 wells), with holder2. 1x 1.2mL pre 1. 1x MPO IgG ELISA microwell plate (12-1 x 8 wells), with holder2. 1x 1.2mL prediluted ELISA Negative Control 3. 1x 1.2mL prediluted MPO IgG ELISA Low Positive4. 1x 1.2mL prediluted MPO IgG ELISA High Positive5. 1x 50mL HRP Sample Diluent6. 1x 25mL HRP Wash Concentrate, 40x concentrate7. 1x 10mL HRP IgG Conjugate, (goat), anti-human IgG8. 1x 10mL TMB Chromogen9. 1x 10mL HRP Stop Solution, 0.344M Sulfuric Acid QUANTA Lite® MPO IgG ELISA INOVA DIAGNOSTICS, INC.
19 07350008750098 Precision i5 Stationary x-ray system intended for obtaining radiographic images portions of t Stationary x-ray system intended for obtaining radiographic images portions of the human body in a clinical environment. The device is not intended for mammography. OMNERA 500A ARCOMA AB
20 07340058410943 CapMPO US CapMPO US WIESLAB Capture MPO-ANCA EURO-DIAGNOSTICA AB
21 07340058410936 CapPR3 US CapPR3 US WIESLAB Capture PR3 ANCA EURO-DIAGNOSTICA AB
22 07340058410707 GCP100 GCP100 WIESLAB antiGBM, ANCA Screen kit EURO-DIAGNOSTICA AB
23 07340058410639 CP111 CP111 WIESLAB ANCA Screen kit EURO-DIAGNOSTICA AB
24 07333066014784 DECC055370 DECC055370 EliA MPOS Well EliA MPOS Well PHADIA AB
25 07333066014777 DECC055360 DECC055360 EliA PR3S Well EliA PR3S Well PHADIA AB
26 07333066013152 83-0008-71 83-0008-71 EliA ANCA/GBM Positive Control 2500/5000 EliA ANCA/GBM Positive Control 2500/5000 PHADIA AB
27 05391516743891 2338970 2338970 Captia™ PR-3 Trinity Biotech CLARK LABORATORIES, INC.
28 05391516743877 2338870 2338870 Captia™ MPO Trinity Biotech CLARK LABORATORIES, INC.
29 04260157080188 ORG519 ORG519 Anti-MPO is an ELISA test system for the quantitative measurement of IgG class a Anti-MPO is an ELISA test system for the quantitative measurement of IgG class autoantibodies against myeloperoxidase (MPO) in human serum or plasma. This product is intended for professional in vitro diagnostic use only. ANTI-MPO (pANCA) ORGENTEC DIAGNOSTIKA GMBH
30 04260157080171 ORG518 ORG518 Anti-PR3 is an ELISA test system for the quantitative measurement of IgG class a Anti-PR3 is an ELISA test system for the quantitative measurement of IgG class autoantibodies against proteinase 3 (PR3) in human serum or plasma. This product is intended for professional in vitro diagnostic use only. ANTI-PR3 (cANCA) ORGENTEC DIAGNOSTIKA GMBH
31 04250289510387 54.051.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. AESKUSLIDES ANCA Formalin AESKU.DIAGNOSTICS GMBH & CO. KG
32 04250289510370 54.050.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. AESKUSLIDES ANCA Ethanol AESKU.DIAGNOSTICS GMBH & CO. KG
33 04250289510363 54.101.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. AESKUSLIDES ANCA Formalin AESKU.DIAGNOSTICS GMBH & CO. KG
34 04250289510356 54.100.US AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutro AESKUSLIDES® ANCA is an indirect immunofluorescence assay utilizing human neutrophil granulocyte coated slides, fixed with Ethanol or Formalin, as a substrate for the qualitative and semi-quantitative determination of anti-neutrophil cytoplasmic autoantibodies (ANCA) in human serum by manual microscopy or with the HELIOS® AUTOMATED IFA SYSTEM.This in vitro diagnostic assay is used as an aid for the diagnosis of ANCA-associated vasculitides (AAV) in conjunction with other clinical and laboratory findings.All suggested results obtained with the HELIOS AUTOMATED IFA SYSTEM must be confirmed by trained personnel. AESKUSLIDES ANCA Ethanol AESKU.DIAGNOSTICS GMBH & CO. KG
35 04250289503556 30-7303US 30-7303US AESKULISA MPO is a solid phase enzyme immunoassay employing highly purified nati AESKULISA MPO is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) from human peripheral blood polymorphnuclear cells for the quantitative and qualitative detection of antibodies against MPO in human serum. Anti-MPO antibodies recognize specific conformational epitopes only accessible on native MPO. The assay is a tool in the differential diagnosis of autoimmune systemic vasculitis. 30'+30'+30' automation incubation. AESKULISA® MPO AESKU.DIAGNOSTICS GMBH & CO. KG
36 04250289503549 30-7302US 30-7302US AESKULISA PR3 sensitive is a solid phase enzyme immunoassay employing highly pur AESKULISA PR3 sensitive is a solid phase enzyme immunoassay employing highly purified native human proteinase 3 (PR3) from human neutrophil granulocytes for the quantitative and qualitative detection of antibodies against proteinase 3 in human serum. Anti-PR3 antibodies recognize specificially conformational epitopes only accessible on native PR3. The assay is an aid in the differential diagnosis of autoimmune vasculitis.30'+30'+30' automation incubation. AESKULISA® PR3 sensitive AESKU.DIAGNOSTICS GMBH & CO. KG
37 04250289501361 3303 AESKULISA MPO is a solid phase enzyme immunoassay employing highly purified nati AESKULISA MPO is a solid phase enzyme immunoassay employing highly purified native myeloperoxidase (MPO) from human peripheral blood polymorphnuclear cells for the quantitative and qualitative detection of antibodies against MPO in human serum. Anti-MPO antibodies recognize specific conformational epitopes only accessible on native MPO. The assay is a tool in the differential diagnosis of autoimmune systemic vasculitis. AESKULISA® MPO AESKU.DIAGNOSTICS GMBH & CO. KG
38 04250289501354 3302 AESKULISA PR3 sensitive is a solid phase enzyme immunoassay employing highly pur AESKULISA PR3 sensitive is a solid phase enzyme immunoassay employing highly purified native human proteinase 3 (PR3) from human neutrophil granulocytes for the quantitative and qualitative detection of antibodies against proteinase 3 in human serum. Anti-PR3 antibodies recognize specificially conformational epitopes only accessible on native PR3. The assay is an aid in the differential diagnosis of autoimmune vasculitis AESKULISA® PR3 sensitive AESKU.DIAGNOSTICS GMBH & CO. KG
39 04049016135975 FC 1201-18010-32 EUROPLUS Granulocyte Mosaic 32 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
40 04049016135968 FC 1201-18010-25 EUROPLUS Granulocyte Mosaic 25 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
41 04049016135951 FC 1201-18010-22 EUROPLUS Granulocyte Mosaic 22 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
42 04049016135944 FC 1201-18010-2 IFA: Granulocyte Mosaic 2 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
43 04049016135937 FC 1201-18010-13 IFA: Granulocyte Mosaic 13 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
44 04049016135920 FC 1201-12010-32 EUROPLUS Granulocyte Mosaic 32 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
45 04049016135913 FC 1201-2450-32 EUROPLUS Granulocyte Mosaic 32 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
46 04049016135906 FC 1201-1050-32 EUROPLUS Granulocyte Mosaic 32 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
47 04049016135890 FC 1201-12010-25 EUROPLUS Granulocyte Mosaic 25 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
48 04049016135883 FC 1201-2450-25 EUROPLUS Granulocyte Mosaic 25 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
49 04049016135876 FC 1201-2450-22 EUROPLUS Granulocyte Mosaic 22 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
50 04049016135869 FC 1201-12010-22 EUROPLUS Granulocyte Mosaic 22 EUROPattern EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG